Austria Parkinsons Disease Market (2025-2031) | Competitive Landscape, Value, Trends, Share, Analysis, Forecast, Growth, Industry, Companies, Outlook, Segmentation, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Austria Country Macro Economic Indicators

3.2 Austria Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 Austria Parkinsons Disease Market - Industry Life Cycle

3.4 Austria Parkinsons Disease Market - Porter's Five Forces

3.5 Austria Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Austria Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 Austria Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Austria Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 Austria Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Parkinson's disease in Austria

4.2.2 Technological advancements in diagnosis and treatment of Parkinson's disease

4.2.3 Growing awareness and focus on research and development in the healthcare sector

4.3 Market Restraints

4.3.1 High cost of Parkinson's disease medications and treatment

4.3.2 Limited access to specialized healthcare services for Parkinson's disease patients

4.3.3 Stringent regulatory requirements for approval of new treatments

6.1 Austria Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Austria Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Austria Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 Austria Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 Austria Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 Austria Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 Austria Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 Austria Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 Austria Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 Austria Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 Austria Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 Austria Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Austria Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Austria Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 Austria Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 Austria Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 Austria Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 Austria Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Austria Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 Austria Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Austria Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 Austria Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 Austria Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 Austria Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 Austria Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7.1 Austria Parkinsons Disease Market Export to Major Countries

7.2 Austria Parkinsons Disease Market Imports from Major Countries

8.1 Average age of onset of Parkinson's disease in Austria

8.2 Number of clinical trials for Parkinson's disease therapies in Austria

8.3 Percentage of Parkinson's disease patients using advanced treatment options

9.1 Austria Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Austria Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 Austria Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Austria Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 Austria Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10.1 Austria Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 Austria Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters